42+ Astrazeneca Vaccine Efficacy Data Gif. An astrazeneca spokesman called the report completely incorrect, while a representative for the university of oxford, which jointly developed the shot, said there is no basis for the claims of very low efficacy. astrazeneca shares traded 1% higher at 1 p.m. Topline data on the astrazeneca vaccine from a phase 3 trial were released in november.
Oxford Astrazeneca Vaccine Shows 70 Efficacy from img.rasset.ie
The company has so far given the vaccine to around 10,000 participants in a us arm. An astrazeneca spokesman called the report completely incorrect, while a representative for the university of oxford, which jointly developed the shot, said there is no basis for the claims of very low efficacy. astrazeneca shares traded 1% higher at 1 p.m. Astrazeneca said media reports about the vaccine's efficacy in the elderly were completely incorrect.
The regulators who oversee the vaccine's trial will review the data and make a decision in the coming weeks.
Cnbc's meg tirrell reports on vaccine distribution and news out of astrazeneca regarding its own vaccine trial. But when efficacy data from the trials were combined — including trials in which volunteers received a low dose followed by a standard dose of vaccine — the vaccine was deemed to be 70% efficacious. The scientists said their clinical trials are ongoing and more data will be forthcoming. Reports that the astrazeneca/oxford vaccine efficacy is as low as 8% in adults over 65 years are completely incorrect, the firm said in a statement late monday.
